Effect of colonoscopy on colorectal cancer incidence and mortality: An instrumental variable analysis

Gastrointestinal Endoscopy

Volumn 76, Issue 2, 2012, Pages

  Jacob, Binu J ^a,b   Moineddin, Rahim ^a,b   Sutradhar, Rinku ^b,c   Baxter, Nancy N ^b,c,d   Urbach, David R ^a,b,c,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e CANCER CARE ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COLONOSCOPY; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION;

EID: 84864116839     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2012.03.247     Document Type: Article

References (46)

1. Canadian Cancer Society/National cancer Institute of Canada Canadian Cancer Statistics 2010, CCS/NCIC, Toronto, Canada http://www cancer ca http://www cancer ca Accessed October 5, 2011
2. Public Health Canada Statistics www phac-aspc gc ca/publicat/ncccs-cndcc/ ccsrec-eng php Accessed October 5, 2011
3. B. Levin, J.S. Barthel, R.W. Burt Colorectal cancer screening clinical practice guidelines J Natl Compr Canc Netw 4 2006 384 420
4. V.P. Deenadayalu, D.K. Rex Colorectal cancer screening: a guide to the guidelines Rev Gastroenterol Disord 7 2007 204 213
5. D.K. Rex Colonoscopy Gastrointest Endosc Clin N Am 10 2000 135 160 viii
6. S.J. Winawer, A.G. Zauber, M.N. Ho The National Polyp Study Workgroup Prevention of colorectal cancer by colonoscopic polypectomy N Engl J Med 329 1993 1977 1981
7. A.D. Muller, A. Sonnenberg Protection by endoscopy against death from colorectal cancer: a case-control study among veterans Arch Intern Med 155 1995 1741 1748
8. H.I. Meissner, N. Breen, C.N. Klabunde Patterns of colorectal cancer screening uptake among men and women in the United States Cancer Epidemiol Biomarkers Prev 15 2006 389 394
9. D.K. Rex, D.A. Johnson, D.A. Lieberman Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology American College of Gastroenterology Am J Gastroenterol 95 2000 868 877
10. B. Levin, D.A. Lieberman, B. McFarland Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 2008 1570 1595
11. D. Leddin, R. Hunt, M. Champion Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening Can J Gastroenterol 18 2004 93 99
12. C. Hassan, G.E. Di, P.J. Pickhardt Cost effectiveness of colonoscopy, based on the appropriateness of an indication Clin Gastroenterol Hepatol 6 2008 1231 1236
13. A.L. Frazier, G.A. Colditz, C.S. Fuchs Cost-effectiveness of screening for colorectal cancer in the general population JAMA 284 2000 1954 1961
14. N.N. Baxter, M.A. Goldwasser, L.F. Paszat Association of colonoscopy and death from colorectal cancer Ann Intern Med 150 2009 1 8
15. L. Rabeneck, L.F. Paszat, R. Saskin Association between colonoscopy rates and colorectal cancer mortality Am J Gastroenterol 105 2010 1627 1632
16. B.J. Jacob, N.N. Baxter, R. Moineddin Social disparities in the use of colonoscopy by primary care physicians in Ontario BMC Gastroenterol 11 2011 102
17. C. Vinden, S. Schultz, L. Rabeneck Use of bowel procedures in Ontario: ICES Atlas 2004 Institute for Clinical Evaluative Sciences Toronto
18. R. Zarychanski, Y. Chen, C.N. Bernstein Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour CMAJ 177 2007 593 597
19. C.N. Klabunde, D. Lanier, M.R. Nadel Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007 Am J Prev Med 37 2009 8 16
20. T.A. Stukel, E.S. Fisher, D.E. Wennberg Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods JAMA 297 2007 278 285
21. A. Basu, J.J. Heckman, S. Navarro-Lozano Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients Health Econ 16 2007 1133 1157
22. M. McClellan, B.J. McNeil, J.P. Newhouse Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables JAMA 272 1994 859 866
23. T.W. Bice, S.B. Boxerman A quantitative measure of continuity of care Med Care 15 1977 347 349
24. J.P. Weiner, B.H. Starfield, D.M. Steinwachs Development and application of a population-oriented measure of ambulatory care case-mix Med Care 29 1991 452 472
25. S. Greenland An introduction to instrumental variables for epidemiologists Int J Epidemiol 29 2000 722 729
26. P. Grootendorst A review of instrumental variables estimation of treatment effects in the applied health sciences Health Service Outcome Res Method 7 2007 159 179
27. Gharibvand L, Liu L. Analysis of survival data with clustered events. Statistics and data analysis, SAS Global Forum Paper 237-2009. Paper presented at SAS Global Forum 2009, Washington DC, March 22-25, 2009.
28. D. Lin, L. Wei, Z. Ying Checking the cox model with cumulative sums of martingale-based residuals Biometrika 80 1993 557 572
29. J.P. Newhouse, M. McClellan Econometrics in outcomes research: the use of instrumental variables Annu Rev Public Health 19 1998 17 34
30. J.A. Rassen, S. Schneeweiss, R.J. Glynn Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes Am J Epidemiol 169 2009 273 284
31. S.J. Winawer, A.G. Zauber, M.N. Ho The National Polyp Study Workgroup Prevention of colorectal cancer by colonoscopic polypectomy N Engl J Med 329 1993 1977 1981
32. H.M. Chiu, J.T. Lin, Y.C. Lee Different bowel preparation schedule leads to different diagnostic yield of proximal and nonpolypoid colorectal neoplasm at screening colonoscopy in average-risk population Dis Colon Rectum 54 2011 1570 1577
33. C. Stock, A.B. Knudsen, I. Lansdorp-Vogelaar Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy Gastrointest Endosc 73 2011 435-43.e5
34. H. Singh, Z. Nugent, S.M. Mahmud Predictors of colorectal cancer after negative colonoscopy: a population-based study Am J Gastroenterol 105 2010 663 673
35. C. Stock, U. Haug, H. Brenner Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends Gastrointest Endosc 71 2010 366 381
36. H. Brenner, M. Hoffmeister, V. Arndt Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study J Natl Cancer Inst 102 2010 89 95
37. H. Singh, Z. Nugent, A.A. Demers The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer Gastroenterology 139 2010 1128 1137
38. A.I. Neugut, B. Lebwohl Colonoscopy vs sigmoidoscopy screening: getting it right JAMA 304 2010 461 462
39. D.A. Lieberman Clinical practice: screening for colorectal cancer N Engl J Med 361 2009 1179 1187
40. G. Hoff, T. Grotmol, E. Skovlund Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial BMJ 338 2009 b1846
41. W. Atkin, I. Kralj-Hans, J. Wardle Colorectal cancer screening: randomised trials of flexible sigmoidoscopy BMJ (Clinical research ed) 341 2010 c4618
42. M.A. Brookhart, J.A. Rassen, P.S. Wang Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects? Med Care 45 2007 S116 S122
43. Y. Bao, N. Duan, S.A. Fox Is some provider advice on smoking cessation better than no advice? An instrumental variable analysis of the 2001 National Health Interview Survey Health Serv Res 41 2006 2114 2135
44. M.A. Brookhart, P.S. Wang, D.H. Solomon Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable Epidemiology 17 2006 268 275
45. E.P. Martens, W.R. Pestman, A. de Boer Instrumental variables: application and limitations Epidemiology 17 2006 260 267
46. K.M. Harris, D.K. Remler Who is the marginal patient? Understanding instrumental variables estimates of treatment effects Health Serv Res 33 1998 1337 1360